Dansk | English
Sitemap
youtube_off.png
linkedin_off.png
Facebook
News

News

Dato
13.06.2016
Rare Neuromuscular Disease Company NMD Pharma Raises USD 3 Million in Seed Financing Round
NMD Pharma today announced the successful completion of a USD 3 million seed financing round. Participants were Lundbeckfonden Emerge, Novo Seeds and Capnova.